Why the study?
Do elevated BNP or NT-pro-BNP levels predict overall mortality and adverse clinical events in patients with pulmonary embolism?
Do elevated BNP or NT-pro-BNP levels predict overall mortality and adverse clinical events in patients with pulmonary embolism?
Elevated BNP or NT-pro-BNP levels identify patients with pulmonary embolism at high risk for complicated in-hospital course and 30-day mortality, though they alone do not justify more invasive treatment.
Elevated BNP/NT-proBNP supports risk stratification in acute PE; confirms strong prognostic association but does not justify invasive therapy changes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Klok et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: